BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 17602639)

  • 1. Synthesis of (-)-agelastatin A by [3.3] sigmatropic rearrangement of allyl cyanate.
    Ichikawa Y; Yamaoka T; Nakano K; Kotsuki H
    Org Lett; 2007 Aug; 9(16):2989-92. PubMed ID: 17602639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereoselective allyl amine synthesis through enantioselective addition of diethylzinc and [1,3]-chirality transfer: synthesis of lentiginosine and polyoxamic acid derivative.
    Ichikawa Y; Ito T; Isobe M
    Chemistry; 2005 Mar; 11(6):1949-57. PubMed ID: 15672433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sterically biased 3,3-sigmatropic rearrangement of chiral allylic azides: application to the total syntheses of alkaloids.
    Lauzon S; Tremblay F; Gagnon D; Godbout C; Chabot C; Mercier-Shanks C; Perreault S; DeSève H; Spino C
    J Org Chem; 2008 Aug; 73(16):6239-50. PubMed ID: 18642871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New total synthesis of the marine antitumor alkaloid (-)-agelastatin A.
    Domostoj MM; Irving E; Scheinmann F; Hale KJ
    Org Lett; 2004 Jul; 6(15):2615-8. PubMed ID: 15255704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allyl cyanate-to-isocyanate rearrangement for the synthesis of quaternary stereocenter with nitrogen substituent.
    Ichikawa Y; Yamauchi E; Isobe M
    Biosci Biotechnol Biochem; 2005 May; 69(5):939-43. PubMed ID: 15914913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total synthesis of the beta-catenin inhibitor, (-)-agelastatin A: a second-generation approach based on radical aminobromination.
    Yoshimitsu T; Ino T; Futamura N; Kamon T; Tanaka T
    Org Lett; 2009 Aug; 11(15):3402-5. PubMed ID: 19588910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereocontrolled synthesis of vicinal diamines by organocatalytic asymmetric Mannich reaction of N-protected aminoacetaldehydes: formal synthesis of (-)-agelastatin A.
    Kano T; Sakamoto R; Akakura M; Maruoka K
    J Am Chem Soc; 2012 May; 134(17):7516-20. PubMed ID: 22486203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Asymmetric total synthesis of (-)-agelastatin a using sulfinimine (N-sulfinyl imine) derived methodologies.
    Davis FA; Deng J
    Org Lett; 2005 Feb; 7(4):621-3. PubMed ID: 15704909
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiospecific formal total synthesis of the tumor and GSK-3 beta inhibiting alkaloid, (-)-agelastatin A.
    Hale KJ; Domostoj MM; Tocher DA; Irving E; Scheinmann F
    Org Lett; 2003 Aug; 5(16):2927-30. PubMed ID: 12889910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expedient synthesis of chiral oxazolidinone scaffolds via rhodium-catalyzed asymmetric ring-opening with sodium cyanate.
    Tsui GC; Ninnemann NM; Hosotani A; Lautens M
    Org Lett; 2013 Mar; 15(5):1064-7. PubMed ID: 23394120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Asymmetric aziridination of cyclic enones using chiral diamine catalysts and its application to the total synthesis of (-)-agelastatin A.
    Menjo Y; Hamajima A; Sasaki N; Hamada Y
    Org Lett; 2011 Nov; 13(21):5744-7. PubMed ID: 21966984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New class of nucleophiles for palladium-catalyzed asymmetric allylic alkylation. Total synthesis of agelastatin A.
    Trost BM; Dong G
    J Am Chem Soc; 2006 May; 128(18):6054-5. PubMed ID: 16669672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total synthesis of lacosamide.
    Stecko S
    J Org Chem; 2014 Jul; 79(13):6342-6. PubMed ID: 24901295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Total synthesis of (+/-)-agelastatin A, a potent inhibitor of osteopontin-mediated neoplastic transformations.
    Dickson DP; Wardrop DJ
    Org Lett; 2009 Mar; 11(6):1341-4. PubMed ID: 19228041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A stereoselective synthesis of the bromopyrrole natural product (-)-agelastatin A.
    Wehn PM; Du Bois J
    Angew Chem Int Ed Engl; 2009; 48(21):3802-5. PubMed ID: 19378315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total synthesis of (-)-agelastatin A.
    Yoshimitsu T; Ino T; Tanaka T
    Org Lett; 2008 Dec; 10(23):5457-60. PubMed ID: 19006318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Asymmetric allylic alkylation in combination with ring-closing metathesis for the preparation of chiral N-heterocycles.
    Teichert JF; Zhang S; van Zijl AW; Slaa JW; Minnaard AJ; Feringa BL
    Org Lett; 2010 Oct; 12(20):4658-60. PubMed ID: 20863080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Total synthesis of (+)-astrophylline.
    Schaudt M; Blechert S
    J Org Chem; 2003 Apr; 68(7):2913-20. PubMed ID: 12662069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A stereodivergent strategy to both product enantiomers from the same enantiomer of a stereoinducing catalyst: agelastatin A.
    Trost BM; Dong G
    Chemistry; 2009 Jul; 15(28):6910-9. PubMed ID: 19533707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A configurational switch based on iridium-catalyzed allylic cyclization: application in asymmetric total syntheses of prosopis, dendrobate, and spruce alkaloids.
    Gnamm C; Brödner K; Krauter CM; Helmchen G
    Chemistry; 2009 Oct; 15(40):10514-32. PubMed ID: 19731272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.